Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2025)

Bausch Health Companies (BHC) reported Asset Writedowns and Impairment of $7.0 million for Q4 2025, down 69.57% on a YoY basis from $23.0 million in Q4 2024, and up 600.0% sequentially from $1.0 million in Q3 2025.

Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2025) Analysis & Trends

Bausch Health Companies (BHC) has 12 years of Asset Writedowns and Impairment data on file, last reported at $7.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment fell 69.57% year-over-year to $7.0 million; the trailing twelve-month figure through Dec 2025 stood at $8.0 million (down 72.41% YoY), and the FY2025 full-year result was $8.0 million, down 72.41% from the prior year.
  • Asset Writedowns and Impairment advanced to $7.0 million in Q4 2025, from $1.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $148.0 million in Q1 2021 to a low of $1.0 million in Q3 2022.
  • A 5-year average of $22.7 million and a median of $8.0 million in 2022 frame the typical range for Asset Writedowns and Impairment.
  • Across the five-year window, Asset Writedowns and Impairment soared 4600.0% in 2021 and tumbled 94.59% in 2022, its largest moves.
  • Tracing BHC's Asset Writedowns and Impairment over 5 years: stood at $21.0 million in 2021, then tumbled by 95.24% to $1.0 million in 2022, then jumped by 300.0% to $4.0 million in 2023, then soared by 475.0% to $23.0 million in 2024, then plunged by 69.57% to $7.0 million in 2025.
  • Business Quant data shows BHC's Asset Writedowns and Impairment at $7.0 million in Q4 2025, $1.0 million in Q3 2025, and $23.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.42 Bn 87.55 Bn -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn
3 Zoetis 32.68 Bn 30.74 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.63 Bn 23.57 Bn 4.39 Bn
5 United Therapeutics 23.16 Bn 21.01 Bn 648.10 Mn
6 RedHill Biopharma 21.80 Bn 21.80 Bn -
7 Viatris 20.34 Bn 18.54 Bn 1.16 Bn
8 Neurocrine Biosciences 17.79 Bn 16.47 Bn 800.70 Mn
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn
10 Bausch Health Companies 1.70 Bn 387.97 Mn 2.52 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.00 Mn
Dec 31, 2025 7.00 Mn
Sep 30, 2025 1.00 Mn
Sep 30, 2025 1.00 Mn
Dec 31, 2024 23.00 Mn
Dec 31, 2024 23.00 Mn
Jun 30, 2024 5.00 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 1.00 Mn
Mar 31, 2024 1.00 Mn
Sep 30, 2023 4.00 Mn
Sep 30, 2023 4.00 Mn
Jun 30, 2023 37.00 Mn
Jun 30, 2023 37.00 Mn
Mar 31, 2023 13.00 Mn
Mar 31, 2023 13.00 Mn
Sep 30, 2022 1.00 Mn
Sep 30, 2022 1.00 Mn
Jun 30, 2022 6.00 Mn
Jun 30, 2022 6.00 Mn